Hosted on MSN44m
FDA Clears Spravato For Monotherapy Depression TreatmentsThe Food and Drug Administration has approved Johnson & Johnson's nasal spray as a standalone treatment for severe forms of ...
Randall K. Fields, the Chief Executive Officer of ReposiTrak, Inc. (NASDAQ:TRAK), recently sold 7,500 shares of the company's common stock. The transaction, which took place on January 21, 2025, was ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback